Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Telfer, Paul
HOPE Kids 2, NCT04218084 / 2017-000903-26: Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease	Terminated	3	236	Europe, US, RoW	Voxelotor, Placebo	Pfizer	Sickle Cell Disease	08/23	11/24
HOPE-KIDS 1, NCT02850406: Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease	Terminated	2	147	Europe, US, RoW	Voxelotor	Pfizer, Pfizer	Sickle Cell Disease	10/23	10/23